Project Details
Description
GOG-286B A Randomized Phase I/II Study of Paclitaxel/Carboplatin/Metformin (NSC#91485) Versus Paclitaxel/Carboplatin/Placebo as Initial Therapy for Measurable Stage III or IV or Recurrent Detrimental Cancer
| Status | Finished |
|---|---|
| Effective start/end date | 1/1/17 → 12/31/20 |
Funding
- GYNECOLOGIC ONCOLOGY GROUP
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.